We are live on ! Find out more
TWST icon

Twist Bioscience
TWST

93 hedge funds and large institutions have $414M invested in Twist Bioscience in 2019 Q4 according to their latest regulatory filings, with 22 funds opening new positions, 33 increasing their positions, 19 reducing their positions, and 7 closing their positions.

New
Increased
Maintained
Reduced
Closed

214% more first-time investments, than exits

New positions opened: 22 | Existing positions closed: 7

100% more funds holding in top 10

Funds holding in top 10: 1 → 2 (+1)

74% more repeat investments, than reductions

Existing positions increased: 33 | Existing positions reduced: 19

11.46% more ownership

Funds ownership: 48.14% → 59.6% (+11%)

11% more funds holding

Funds holding: 84 → 93 (+9)

11% more capital invested

Capital invested by funds: $374M → $414M (+$39.7M)

Holders
93
Holders Change
+9
Holders Change %
+10.71%
% of All Funds
1.83%
Holding in Top 10
2
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+100%
% of All Funds
0.04%
New
22
Increased
33
Reduced
19
Closed
7
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Capital World Investors
Capital World Investors
California
+$16.5M
2
Alyeska Investment Group
Alyeska Investment Group
Illinois
+$11.4M
3
BlackRock
BlackRock
New York
+$7.27M
4
Millennium Management
Millennium Management
New York
+$6.93M
5
JP Morgan Chase
JP Morgan Chase
New York
+$4.42M

Top Sellers

Rank Fund Capital Flow
1
EA
Emerald Advisers
Pennsylvania
-$5.33M
2
EMFAT
Emerald Mutual Fund Advisers Trust
Pennsylvania
-$4.9M
3
IECM
Intrinsic Edge Capital Management
Illinois
-$4.22M
4
CM
Castleark Management
Illinois
-$3.4M
5
Barclays
Barclays
United Kingdom
-$1.52M
Name Holding Trade Value Shares
Change 		Change in
Stake
P3I
26
Progeny 3 Inc
Washington
$3.95M – – –
Citadel Advisors
27
Citadel Advisors
Florida
$3.08M +$1.3M +55,525 +61%
Charles Schwab
28
Charles Schwab
California
$2.97M +$139K +5,960 +4%
Ensign Peak Advisors
29
Ensign Peak Advisors
Utah
$2.8M +$3.12M +133,456 New
Ameriprise
30
Ameriprise
Minnesota
$2.3M +$103K +4,418 +4%
AG
31
Artal Group
Luxembourg
$2.1M – – –
Squarepoint
32
Squarepoint
New York
$2.04M -$220K -9,387 -9%
N
33
Nuveen
North Carolina
$1.79M -$559K -23,898 -22%
IECM
34
Intrinsic Edge Capital Management
Illinois
$1.67M -$4.22M -180,311 -69%
Bank of New York Mellon
35
Bank of New York Mellon
New York
$1.63M +$71.5K +3,054 +4%
Hudson Bay Capital Management
36
Hudson Bay Capital Management
Connecticut
$1.57M +$1.76M +75,000 New
Allianz Asset Management
37
Allianz Asset Management
Germany
$1.4M +$392K +16,751 +34%
Two Sigma Investments
38
Two Sigma Investments
New York
$1.29M +$1.44M +61,537 New
ACM
39
Asymmetry Capital Management
California
$1.14M +$377K +16,116 +42%
AG
40
Algert Global
California
$1.14M +$1.04M +44,459 +460%
California Public Employees Retirement System
41
California Public Employees Retirement System
California
$1.05M +$177K +7,576 +18%
Goldman Sachs
42
Goldman Sachs
New York
$931K -$278K -11,895 -21%
CFM
43
Comprehensive Financial Management
California
$890K +$991K +42,363 New
PP
44
PDT Partners
New York
$845K +$21.9K +934 +2%
Deutsche Bank
45
Deutsche Bank
Germany
$810K -$657K -28,091 -42%
California State Teachers Retirement System (CalSTRS)
46
California State Teachers Retirement System (CalSTRS)
California
$711K – – –
Morgan Stanley
47
Morgan Stanley
New York
$699K +$543K +23,196 +230%
State of Wisconsin Investment Board
48
State of Wisconsin Investment Board
Wisconsin
$668K – – –
CS
49
Credit Suisse
Switzerland
$628K +$402K +17,173 +135%
IP
50
Intellectus Partners
California
$619K – – –
1
2
3 4

TWST Hedge Fund Activity: Q4 2019 in Review

93 of the 5,075 institutional investors tracked by Wall St. Rank reported a position in Twist Bioscience (TWST) for Q4 2019, worth a combined $414M — up 11% from $374M a quarter earlier.

Buyers outnumbered sellers: 22 funds opened new TWST positions and 7 closed out — a net gain of 15 holders — while 33 added to existing stakes and 19 trimmed.

The largest buyer was Capital World Investors, opening a new position worth an estimated $16.5M. The largest seller was Emerald Advisers, cutting an estimated $5.33M.

  • 93 institutional investors held Twist Bioscience (TWST) as of Q4 2019, up from 84 in Q3 2019.
  • Funds reported $414M of Twist Bioscience stock for Q4 2019, up 11% quarter-over-quarter.
  • 22 funds opened new Twist Bioscience positions in Q4 2019 and 7 closed out, a net change of +15 holders.
  • The largest Twist Bioscience buyer in Q4 2019 was Capital World Investors, an estimated $16.5M added.
  • The largest Twist Bioscience seller in Q4 2019 was Emerald Advisers, an estimated $5.33M sold.

Based on aggregated 13F filings for Q4 2019.